Epidiolex ® (cannabidiol) – New and expanded indications
July 31, 2020 - The FDA approved Greenwich Biosciences’ Epidiolex (cannabidiol) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS) or tuberous sclerosis complex (TSC) in patients 1 years of age and older.
Top